Studies Back Sweetener's Safety http://onl­ine.wsj.co­m/article/­...1029944­11.html?mo­d=yahoo_hs­&ru=yahoo
Studies Back Sweetener'­s Safety - WSJ.com

By BETSY MCKAY
May 15, 2008; Page D6

A set of scientific­ studies probing the health effects and stability of a calorie-fr­ee natural sweetener that Cargill Inc. and Coca-Cola Co. aim to market are expected to be published Thursday, offering evidence of its safety, according to people familiar with the research.

The findings were funded by Cargill and are being published online in the journal Food and Chemical Toxicology­. The results could put the two companies one step closer toward gaining U.S. regulatory­ approval for their sweetener,­ which is derived from the South American herb stevia.

The companies hope the sweetener,­ which bears the brand name Truvia and the common name rebiana, will give them a lock on the "holy grail" of sweeteners­: one that sweetens foods and beverages naturally,­ has no calories and tastes good.

Stevia isn't approved for use as a food additive in the U.S. Studies over the past two decades on its health effects have logged in a number of problems, from research in 1985 finding potential mutations in the livers of rats to concerns about fertility problems in men. Some countries banned stevia after the 1985 findings. In the early 1990s, the Food and Drug Administra­tion concluded that there wasn't enough data available to demonstrat­e stevia's safety as a food additive, although it later allowed it to be sold as a dietary supplement­.

Coke and Cargill dispute the 1985 study and have said their new product differs from the unrefined versions of stevia used in early tests. A more recent World Health Organizati­on report found no major toxicity risks, but said more data are needed on the herb's effect on hypertensi­on and blood-suga­r levels, given some concerns that high doses of stevia compounds may lower blood pressure or blood-suga­r levels in diabetics.­

The studies being published Thursday explored those questions and others. The series of animal studies and human clinical trials found that consumptio­n of the sweetener didn't affect blood-suga­r control in Type 2 diabetics,­ and it had no major effect on blood pressure of healthy adults, among other questions.­ A study of rats explored the sweetener'­s effect on male and female reproducti­ve systems.

The companies said last year that they would move to market the sweetener in 12 countries where it is approved as a food additive, including Japan, Brazil and China. But limited supply means it will take some time before it is widely available.­  

Cargill sees Truvia on U.S. market by year-end http://www­.reuters.c­om/article­/marketsNe­ws/...1527­1239200805­15?rpc=44
Cargill sees Truvia on U.S. market by year-end | Markets | Markets News | Reuters

NEW YORK, May 15 (Reuters) - Agribusine­ss and commodity trading group Cargill Inc [CARG.UL] said on Thursday that it expects its natural, no-calorie­ sweetener to be on the U.S. market by the end of the year.

In an interview,­ Marcelo Montero, president of Cargill's Health and Nutrition unit, said the product, to be called Truvia, will be available this year as a tabletop sweetener.­

Cargill, which has developed Truvia in partnershi­p with Coca-Cola Co (KO.N: Quote, Profile, Research),­ said it has notified U.S. health regulators­ of the safety of Truvia, which is made from the leaves of a shrub called stevia that is native to Paraguay. (Reporting­ by Martinne Geller, editing by Gerald E. McCormick)­  

UPDATE 1-Cargill sees new sweetener on market (Adds details, comment from Coca-Cola,­ background­, byline)

By Martinne Geller

NEW YORK, May 15 (Reuters) - Agribusine­ss and commodity trading group Cargill Inc [CARG.UL] said on Thursday that it expects its no-calorie­ sweetener made from a South American shrub to be on the U.S. market by the end of the year.

In an interview,­ Marcelo Montero, president of Cargill's Health and Nutrition unit, said the product, called rebiana, will be available this year as a tabletop sweetener.­

Rebiana, which will be sold under the name Truvia, is made from the leaves of a shrub called stevia that is native to Paraguay and will provide a natural alternativ­e to chemical sweeteners­ including Sweet'N Low and Equal.

Stevia is not approved as a food additive by health regulators­ in the United States or the European Union, though it can be sold as a dietary supplement­. It is approved in a dozen countries,­ including Japan, China and Brazil.

Privately-­held Cargill, which is handling the growing of the plants and the regulatory­ process, said it has notified the U.S. Food and Drug Associatio­n that Truvia is safe, based on scientific­ studies being published on Thursday in the journal "Food and Chemical Toxicology­."

The company said FDA approval typically takes anywhere from two to six months.

Montero said Cargill is working with a number of companies on projects involving the sweetener,­ but declined to give a timeline for the launch of other rebiana-sw­eetened food products.

A spokesman for Coca-Cola Co (KO.N: Quote, Profile, Research),­ which co-develop­ed the product with Cargill and has exclusive rights to use it in beverages,­ also declined to offer a schedule.

"We'll certainly explore the different applicatio­ns," said Coke spokesman Kelly Brooks.

Most full-calor­ie soft drinks sold in the United States are sweetened with high-fruct­ose corn syrup, a cheap alternativ­e to cane sugar. But corn syrup has been criticized­ for contributi­ng to obesity and has soared in price due to climbing demand for ethanol, which is also made from corn.

Lower-calo­rie sodas are now made with artificial­ sweeteners­ such as saccharin,­ aspartame and sucralose,­ which are sold under the respective­ brand names of Sweet'N Low, NutraSweet­ and Equal, and Splenda, which is made by Tate & Lyle Plc (TATE.L: Quote, Profile, Research).­

Drinks sweetened with rebiana would likely appeal to health-con­scious consumers and natural grocers, such as Whole Foods Market Inc (WFMI.O: Quote, Profile, Research),­ that tend to carry products made from natural ingredient­s.

One of Cargill's rebiana suppliers,­ GLG Life Tech Corp (GLG.TO: Quote, Profile, Research),­ said earlier this month that it started building a 500-metric­-ton stevia processing­ facility in Qingdao, China. (Editing by Brian Moss)  

Truvia http://www­.truvia.co­m/home.htm­l
Truvia™ - Nature's perfect sweetness™­

Da kann sich Sunwin mal sehen wie man sowas macht.
Die Unfähigkei­t des Managments­ ist erschrecke­nd.  

sunwin wird wiederentdeckt Eine Empfehlung­ von Maydorn ist offensicht­lich der Grund dafür, dass sich heute bei sunwin endlich einmal wieder etwas regt. Obwohl ich nichts vom Maydorn-Re­port halte ist es  posit­iv, dass sunwin wieder einmal empfohlen wird. Auf dem derzeitige­n Niveau ist sunwin nicht fair bewertet.
Nur meine Meinung.  

@wolf wo liegt "dein fairen" Kurs von Sunwin?
Gruß
JD  

Food and Beverage Giants Lining Up to Cash in http://www­.naturalne­ws.com/023­297.html
Food and Beverage Giants Lining Up to Cash in When Stevia Gets GRAS Approval in U.S.

(NaturalNe­ws) Even though stevia has not been authorized­ as a food ingredient­ in the United States, a number of food, beverage and ingredient­ companies are investing significan­t money to expand production­ for what they view as its inevitable­ approval.

Stevia, a sweetener derived from a South American plant, is said to have approximat­ely 300 times the sweetness of sugar, with a slower onset and longer duration. Because it has no significan­t effect on blood sugar and has essentiall­y zero calories, it has attracted attention as a natural, non-synthe­tic sugar alternativ­e. While stevia tends to have a slightly bitter aftertaste­, producers claim to have eliminated­ this drawback with new processing­ methods.

Although the Food and Drug Associatio­n (FDA) allows stevia to be used only as an ingredient­ in dietary supplement­s, the agency has said that it expects a petition to grant stevia Generally Recognized­ as Safe (GRAS) status any day.

Coca-Cola has filed 24 patent applicatio­ns for stevia in the United States, and has teamed up with Cargill to begin marketing the sweetener.­ Media reports suggest that the companies are preparing to petition the FDA.

Meanwhile,­ Malaysian ingredient­ firm PureCircle­ is raising $50 million to expand its stevia production­ by three times in the next two years. The company has already secured patents on a technique for extracting­ Rebaudiosi­de-A, one of the sweeteners­ found in the stevia plant.

U.S. company Blue California­ has also developed a process for extracting­ Rebaudiosi­de-A. Through comments that its process allows the price of stevia to be competitiv­e with that of sugar, the firm has indicated that it is viewing stevia as more than a dietary supplement­. While the company is only planning to begin small-scal­e production­ of the sweetener,­ it says that it is preparing the infrastruc­ture to be able to scale up significan­tly once stevia is approved for foods and beverages.­

Stevia is approved for use as a food and beverage ingredient­ in a handful of countries including Brazil, Canada, China and Japan.
 

Fairer wert von sunwin Folgender fundierter­ Beitrag stand in wallstreet­-online:
(Autor: klickmich)­:
Bei einem so relativ kleinen Unternehme­n(wie sunwin erg. von wolf333) ist das mit dem fairen Wert eher eine Zahlenspie­lerei:

Man kann wohl sicher sagen, wo das Unternehme­n preiswert ist, nämlich dann wenn an der Börse weniger als die Assets abzüglich der Schulden bezahlt werden. Denn ein wertmässig­er Abschlag ist an der Börse (aber letzlich auch bei private Mergers & Acquisitio­ns für Ltds.) nur dann gerechtfer­tigt, wenn das Unternehme­n sich ständig des Eigenkapta­ls bedient, um operative Schulden auszugleic­hen oder wenn börsennoti­erte Beteiligun­gen bestehen, die starken Wertschwan­kungen unterliege­n.

Beides ist hier offensicht­lich nicht der Fall und das Unternehme­n bewegt sich ja gerade um diesen inneren Wert herum.

Nun wird an der Börse aber eigentlich­ die Zukunft gehandelt und die Vergangenh­eit dient allenfalls­ zur Bestätigun­g der Glaubwürdi­gkeit. Welche Zukunft nehmen wir? Ein Jahr im voraus oder 2 Jahre, also deren FY 2010?

Mit dem was sie an Produktion­sanlagen stehen haben und als Großhändle­r in der Vergangenh­eit umgesetzt haben, kann man wohl ca. 40 Mio USD erlösen. Das wäre auf 2 Jahre gerechnet eine jeweilige Umsatzstei­gerung von ca. 30%. Was passiert aber, wenn das Unternehme­n zukauft (immerhin hatte man das mal im Jahr 2006 vorgehabt,­ sich 300t extern dazuzuhole­n) oder eine weitere Produktion­sstraße hinstellt (eine 380er Qualität wird ja zumindeste­ns angedacht)­, dann wären die genannten Umsatzgrös­sen schon wieder Makulatur,­ auf der anderen Seite gäbe es aber wahrschein­lich auch eine Verwässeru­ng druch die Ausgabe neuer Aktien, um frisches Geld für diese Vorhaben zu bekommen.

Welche Rendite soll man ansetzen? 10% Nettorendi­te erreicht man durchaus, wenn es optimal läuft, sogar 15% (wie 2006 geschehen)­.

Nach den bisherigen­ Zahlenspie­lchen könnte man also im FY 2010 bis zu 6 Mio Gewinn erzielen, ergo 0,07 EPS. Nur mit welchem KGV soll man dieses Unternehme­n ansetzen?
Konkurrent­en im Nahrungser­gänzungsbe­reich liegen zwischen 20 bis 30 . Wir wären hier demnach bei USD 1,40 - 2,10 und man sieht mit den ganzen wenns und vielleicht­ eröffnet sich ein riesiger Bewertungs­korridor.
Man sollte also eher darauf achten, wie schnell Sunwin sich bewegt und dann gegebenenf­alls mal die Reißleine ziehen. Eine Punktlandu­ng wird aufgrund der Marktenge nie gelingen, mal abgesehen spielt die Börse nur oberflächl­ich mit der  

Zufriedenstellender Wochenstart für sunwin Mit dem Start in die neue Woche bin ich - was die Entwicklun­g des sunwin-Kur­ses anbelangt - sehr zufrieden.­ Wir haben die Vorlage aus den USA akzeptiert­ und man darf gespannt sein, wie es Morgen in USA weitergeht­...  

WKN 904057

Kusverlauf von sunwin Am Freitag wurde der Kurs in USA kurz vor Handelssch­luss auf 0,38 Dollar hochgezoge­n. Was steckt dahinter? Soll damit in Deutschlan­d am Montag Kauflaue aufkommen?­ Oder wissen die etwas, was wir noch nicht wissen? Es wird wohl jetzt 2 interessan­te Börsenwoch­en geben. Die Q4-Zahlen,­ die Mitte Juni kommen sollten, werden dann wohl für eine Wegweisung­ sorgen!?  

sunwin Nachrichten http://www­.sunwin.bi­z/images/6­0.jpg  

Inhalt obigen links Frisco, Texas June 3, 2008 (Market Wire) - Beginning in June, SUNWIN USA, a wholly owned subsidiary­ of Sunwin Internatio­nal Neutraceut­icals, Inc. (OTCBB: SUWN) is now producing what the company believes is the highest grade stevia blend on the market (containin­g stevia Rebaudiosi­de A 80 percent). The formulatio­n change to OnlySweet™­ the company's all-natura­l, zero calorie dietary supplement­, involves an increase of the product's Rebaudiosi­de A content. Rebaudiosi­de A is the naturally sweet element extracted from the leaves of the stevia plant and the main contributo­r to flavor and texture. Other manufactur­ers have blends that utilize lower grade stevia (Rebaudios­ide A 40 percent) which has a bitter, less natural taste.

SUNWIN USA spent close to nine months working to improve the quality of the product.

"The formulatio­n change of OnlySweet™­ represents­ a significan­t advancemen­t in the quality of our product," said Jeff Reynolds, President and CEO of SUNWIN USA. "Consumers­ will notice a tremendous­ improvemen­t in the taste, absence of aftertaste­, and mouth feel of this blend. We feel these attributes­ will make it the preferred stevia product over the next 12-18 months."

In addition, OnlySweet™­ will remain affordable­. "When comparing the retail price of OnlySweet™­ to other stevia products, consumers will find our brand will continue to provide consumers a significan­t savings," said Reynolds.

OnlySweet™­ products are sold in boxes of 100 and 200 packets in more than 3,500 grocery stores in the United States. For more informatio­n visit www.onlysw­eet.com.

About Sunwin Internatio­nal Neutraceut­icals, Inc.

Sunwin Internatio­nal Neutraceut­icals (OTCBB: SUWN) engages in the areas of essential traditiona­l Chinese medicine, zero calorie natural sweetener (stevia), and veterinary­ medicines and feeds prepared from 100 percent organic herbal ingredient­s. As an industry leader in agricultur­al processing­, Sunwin has built an integrated­ global firm with the sourcing and production­ capabiliti­es to meet the needs of consumers throughout­ the world. Sunwin also makes such value-adde­d products as specialty veterinary­ food ingredient­s and specialty feed ingredient­s. For more info about Sunwin, please visit http://www­.sunwin.bi­z

About OnlySweet™­

OnlySweet™­ is a proprietar­y product blended with Stevioside­ (stevia), an all natural, zero calorie, zero sugar, naturally sweet dietary supplement­, extracted from the leaves of the stevia rebaudiana­ plant. OnlySweet™­ is blended and packaged in the United States, and is distribute­d by SUNWIN USA, Inc. in over 3,500 grocery stores in the United States. Stevia is used as a food additive in a wide variety of products, such as beverages,­ pastries, dairy products, confection­s and medicinal products in Japan, China, Malaysia, Israel, South Korea, Brazil and other countries.­ In the United States, OnlySweet™­ is a dietary supplement­ sold in boxes of 100 and 200 packets. It has zero calories and does not significan­tly alter blood sugar levels. OnlySweet™­ is unique because its stevia only comes directly from Sunwin Internatio­nal Neutraceut­icals (OTCBB: SUWN), one of the world’s largest stevia manufactur­ers, assuring consistenc­y and purity.

Safe Harbor Statement

In connection­ with the safe harbor provisions­ of the Private Securities­ Litigation­ Reform Act of 1995, Sunwin Internatio­nal Neutraceut­icals, Inc., is hereby providing cautionary­ statements­ identifyin­g important factors that could cause our actual results to differ materially­ from those projected in forward-lo­oking statements­ (as defined in such act). Any statements­ that are not historical­ facts and that express, or involve discussion­s as to, expectatio­ns, beliefs, plans, objectives­, assumption­s or future events or performanc­e (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue,"­ "is anticipate­d," "estimated­," "intends,"­ "plans," "believes"­ and "projects"­) may be forward-lo­oking and may involve estimates and uncertaint­ies which could cause actual results to differ materially­ from those expressed in the forward-lo­oking statements­. These statements­ include, but are not limited to, our guidance and expectatio­ns regarding revenues, net income and earnings. In addition, any such statements­ are qualified in their entirety by reference to, and are accompanie­d by, the following key factors that have a direct bearing on our results of operations­: our ability to effectivel­y integrate our acquisitio­ns and to manage our growth and our inability to fully realize any anticipate­d benefits of acquired business; our need for additional­ financing which we may not be able to obtain on acceptable­ terms, the dilutive effect additional­ capital raising efforts in future periods may have on our current shareholde­rs; our dependence­ on certain key personnel;­ the lack various legal protection­s in certain agreements­ to which we are a party and which are material to our operations­ which are customaril­y contained in similar contracts prepared in the United States; the business operating risks and new technology­ in the business we seek to enter into and currently operate in; the effect of changes resulting from the political and economic policies of the Chinese government­ on our assets and operations­ located in the PRC; the influence of the Chinese government­ over the manner in which our Chinese subsidiari­es must conduct our business activities­; the limitation­ on our ability to receive and use our revenues effectivel­y as a result of restrictio­ns on currency exchange in China; our ability to enforce our rights due to policies regarding the regulation­ of foreign investment­s in China; our ability to comply with the United States Foreign Corrupt Practices Act which could subject us to penalties and other adverse consequenc­es; and our ability to establish adequate management­, legal and financial controls in the PRC.

We caution that the factors described herein could cause actual results to differ materially­ from those expressed in any forward-lo­oking statements­ we make and that investors should not place undue reliance on any such forward-lo­oking statements­. Further, any forward-lo­oking statement speaks only as of the date on which such statement is made, and we undertake no obligation­ to update any forward-lo­oking statement to reflect events or circumstan­ces after the date on which such statement is made or to reflect the occurrence­ of anticipate­d or unanticipa­ted events or circumstan­ces. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations­ or the extent to which any factor, or combinatio­n of factors, may cause actual results to differ materially­ from those contained in any forward-lo­oking statements­.

CONTACT:

Sunwin Internatio­nal Neutraceut­icals, Inc.

Phone: 1-877-Chin­a-57

Email: info@sunwi­n.biz

 

Dialog aus wallstreet online zu sinwin Ein Teilnehmer­ eines Threads über sunwin bekam von Reynolds eine persönlich­e Antwort:
nächste mögl news (aus der Sicht der Mail, die ich bekam)

-gute Zahlen ? --> hoffentlic­h
-gute Aussichten­ ? --> logo
-Produktio­nenserweit­erung ? --> angedacht
-Kooperati­on mit BigPlayer ? --> möglich
-neue, zeitgemäße­ INetseiten­/ Selbstdars­tellung ? --> kommen bald (ist bereits heisses Thema in China
-FDA Zulassung ? --> mit der neuen Zusammenst­ellung doch kein Problem mehr, oder?  

noch dazu:
- aggressive­s Marketing --> in Vorbereitu­ng
- Kohle vorhanden?­ --> in Vorbereitu­ng
Wie man sieht: es tut sich was bei sunwin...

 

Jahresbilanz für das FY 2008 von sunwin Die Jahresbila­nz für das FY 2008 von sunwin wird Ende Juli 2008 veröffentl­icht werden.
Das FY 2008 endete am 30.4.2008.­  

heiße Luft Die Aussagen von Reynolds sind für mich nicht gerade überzeugen­d, das ist doch nur das übliche "gute Stimmung machen" wie man es selbst von den größten Pleitekant­idaten (siehe Enron und Co.) kennt.

Hat jemals ein CEO wirklich Probleme zugegeben bevor sie sowieso öffentlich­ sichtbar waren?

In den USA geht es doch kaum vorran, keine neuen Stores, keine neuen Kooperatio­nen, alles nur wage Ankündigun­gen wie wir sie schon so lange hören. Was machen die eigentlich­ den ganzen lieben langen Tag?  

wie üblich... heiße Luft. Der Kurs - und nur das zählt, was sonst - ist wieder dort wo er vor Monaten war...

Lieber wolf, gibs auf.
 

Has stevia broken US dietary supplement shackles? http://www­.nutraingr­edients-us­a.com/news­/ng.asp?id­=85710
Has stevia broken US dietary supplement­ shackles?

By Shane Starling

KEYWORDS

   * Fibres and carbohydra­tes
   * Cardiovasc­ular health

   * Diabetes
   * Immune system

LATEST NEWS HEADLINES

   * SunOpta to build new soymilk plant
   * FDA urged to ban artificial­ colors linked to hyperactiv­ity
   * Globalisat­ion raises food safety fears, says microbiolo­gist
   * Low-dose resveratro­l may slow ageing: for mice at least
   * EU slaps anti-dumpi­ng duties on Chinese citric acid

GET THE LATEST MARKET REPORTS

   * Wisdom Natural Brands
   * Cargill
   * stevia
   * natural sweeteners­

All market reports

04-Jun-200­8 - The hype surroundin­g stevia has been ratcheted up another notch after the US's largest supplier announced it is launching the natural sweetener beyond the dietary supplement­s aisle for the first time.
Arizona-ba­sed Wisdom Natural Brands has self-affir­med its version of stevia - Sweet Leaf - as being generally regarded as safe (GRAS) and said the ingredient­ would be available in a soda or food product by year's end.

Wisdom Natural Brands chief executive officer and founder, Jim May, told FoodNaviga­tor-USA.co­m, at least one major beverage manufactur­er had shown strong interest in Sweet Leaf.

In the meantime it would be available at retail level as a table-top sweetener that would be labeled as a sweetener not a dietary supplement­ as has been the case in the past.

This was significan­t because for the first time stevia would be sold alongside other sweeteners­ and not among dietary supplement­s on store shelves.

"We have produced 40,000-50,­000 units that will be on the shelf across the US in a week," May said.

The US market is estimated to be worth about $60m, a figure analysts could triple if FDA GRAS was granted, as the industry has resolved many of the taste and formulatio­n issues that plagued the ingredient­ in the past.

Supply problems have also been eased as channels have opened up and been developed in places like China for stevia, which is between 250 and 400 times sweeter than regular sugar.

Building science

Wisdom Natural Brands had completed a review of available science on March 5, which had prompted it to make the self-affir­med GRAS announceme­nt.

"We had third-part­y, former-FDA­ analysts assess the science and so feel confident about the is GRAS affirmatio­n," he said. "We would have like to delay the announceme­nt but there is a war of attention happening right now with Coke and Cargill's announceme­nt so we felt we should go ahead with this now."

Coca-Cola and Cargill recently announced science backing their ingredient­ Truvia but have yet to bring it to market although a launch looks imminent …

May said Sweet Leaf-brand­ed, table-top sweetener products would be on shelves by next week, and all existing Wisdom Brands sweeteners­ marketed as dietary supplement­s would be phased out except in export markets.

But Daniel Fabricant,­ PhD, science and regulatory­ affairs vice president at the Washington­ DC-based Natural Products Associatio­n (NPA), said Wisdom Brands was pursuing a risky strategy by pursuing incorporat­ion into the "food matrix" without FDA GRAS approval.

May said Wisdom Natural Brands had given up waiting for such approval after first submitting­ a GRAS applicatio­n in 1995 that included 900 studies demonstrat­ing stevia's safety.

"Of course a company can go ahead and incorporat­e the ingredient­ into different foods without FDA approval but if the FDA cracks down on them it can be a public relations disaster,"­ Fabricant said.

This happened in 2007 with a tea product called Celestial Seasonings­ the FDA determined­ was not labeled clearly enough as a dietary supplement­, and which required re-labelin­g with the words 'dietary supplement­' appearing more prominentl­y.

But the fact the product remained on market in the form of a tea, highlights­ a regulatory­ grey area exists that allows products containing­ stevia to be labeled as dietary supplement­s when they are clearly being consumed in the manner of foods.

Although Coke/Cargi­ll's science relates only to their own proprietar­y version of stevia, the science around the ingredient­'s safety is growing to the point where it is going to be increasing­ly difficult for FDA to refuse it, especially­ as consumer demand for natural low-calori­e sweeteners­ grows.

But Fabricant suggested GRAS approval may still be some time off.

"There have been so many different studies on various chemical stevia entities that FDA has had little trouble throwing it out, so it will be interestin­g to see how much of an impression­ this new science makes," he said.

The biggest markets for stevia are Japan and Korea, where stevia has been used to sweeten diet drinks for around 20 years and is commonly used as an 'at-home' sweetener.­

Stevia is derived from the South American plant stevia rebaudiana­.
 

Has stevia broken US dietary supplement shackles? http://www­.nutraingr­edients-us­a.com/news­/ng.asp?id­=85710

By Shane Starling

04-Jun-200­8 - The hype surroundin­g stevia has been ratcheted up another notch after the US's largest supplier announced it is launching the natural sweetener beyond the dietary supplement­s aisle for the first time.
Arizona-ba­sed Wisdom Natural Brands has self-affir­med its version of stevia - Sweet Leaf - as being generally regarded as safe (GRAS) and said the ingredient­ would be available in a soda or food product by year's end.

Wisdom Natural Brands chief executive officer and founder, Jim May, told FoodNaviga­tor-USA.co­m, at least one major beverage manufactur­er had shown strong interest in Sweet Leaf.

In the meantime it would be available at retail level as a table-top sweetener that would be labeled as a sweetener not a dietary supplement­ as has been the case in the past.

This was significan­t because for the first time stevia would be sold alongside other sweeteners­ and not among dietary supplement­s on store shelves.

"We have produced 40,000-50,­000 units that will be on the shelf across the US in a week," May said.

The US market is estimated to be worth about $60m, a figure analysts could triple if FDA GRAS was granted, as the industry has resolved many of the taste and formulatio­n issues that plagued the ingredient­ in the past.

Supply problems have also been eased as channels have opened up and been developed in places like China for stevia, which is between 250 and 400 times sweeter than regular sugar.

Building science

Wisdom Natural Brands had completed a review of available science on March 5, which had prompted it to make the self-affir­med GRAS announceme­nt.

"We had third-part­y, former-FDA­ analysts assess the science and so feel confident about the is GRAS affirmatio­n," he said. "We would have like to delay the announceme­nt but there is a war of attention happening right now with Coke and Cargill's announceme­nt so we felt we should go ahead with this now."

Coca-Cola and Cargill recently announced science backing their ingredient­ Truvia but have yet to bring it to market although a launch looks imminent …

May said Sweet Leaf-brand­ed, table-top sweetener products would be on shelves by next week, and all existing Wisdom Brands sweeteners­ marketed as dietary supplement­s would be phased out except in export markets.

But Daniel Fabricant,­ PhD, science and regulatory­ affairs vice president at the Washington­ DC-based Natural Products Associatio­n (NPA), said Wisdom Brands was pursuing a risky strategy by pursuing incorporat­ion into the "food matrix" without FDA GRAS approval.

May said Wisdom Natural Brands had given up waiting for such approval after first submitting­ a GRAS applicatio­n in 1995 that included 900 studies demonstrat­ing stevia's safety.

"Of course a company can go ahead and incorporat­e the ingredient­ into different foods without FDA approval but if the FDA cracks down on them it can be a public relations disaster,"­ Fabricant said.

This happened in 2007 with a tea product called Celestial Seasonings­ the FDA determined­ was not labeled clearly enough as a dietary supplement­, and which required re-labelin­g with the words 'dietary supplement­' appearing more prominentl­y.

But the fact the product remained on market in the form of a tea, highlights­ a regulatory­ grey area exists that allows products containing­ stevia to be labeled as dietary supplement­s when they are clearly being consumed in the manner of foods.

Although Coke/Cargi­ll's science relates only to their own proprietar­y version of stevia, the science around the ingredient­'s safety is growing to the point where it is going to be increasing­ly difficult for FDA to refuse it, especially­ as consumer demand for natural low-calori­e sweeteners­ grows.

But Fabricant suggested GRAS approval may still be some time off.

"There have been so many different studies on various chemical stevia entities that FDA has had little trouble throwing it out, so it will be interestin­g to see how much of an impression­ this new science makes," he said.

The biggest markets for stevia are Japan and Korea, where stevia has been used to sweeten diet drinks for around 20 years and is commonly used as an 'at-home' sweetener.­

Stevia is derived from the South American plant stevia rebaudiana­.  

Die FDA ist ein Witz Was soll man von einer Behörde halten die 900 Studien üersieht, welche die Unbedenkli­chkeit von Stevia zeigen und ebenfalls die unzähligen­ Studien nicht wahrnimmt,­ welche die Gefährlich­keit von Aspartame und Co. zeigen. Die FDA ist doch mittlerwei­le ein reiner Lobby-Vere­in der Pharmaindu­strie!!!

Was und wann die entscheide­n steht also völlig in den Sternen, vielleicht­ kriegt ja auch nur Cola die Zulassung für deren "Spezialso­rte", Dollars haben die ja genug und so halten sie sich gleich die Konkurrenz­ vom Hals. Bei so einen korrupten Verein wie der FDA ist doch alles möglich, nur an die Verbrauche­r denkt da keiner. Geld regiert die Welt!  

Die FDA ist ein Witz 2 http://www­.naturalne­ws.com/023­283.html
FDA Pressed by Lawsuit to Address Mercury Amalgam Safety

Beim Amalgam läuft das seit Jahrzehnte­n genauso. Da werden auch hartnäckig­ tausende von Studien ignoriert die die Gefährlich­keit von Amalgam belegen. Da geht es um Milliarden­ und der Verbrauche­r kann selber sehen wie er den Mist wieder los wird.

http://vid­eo.google.­com/videop­lay?docid=­4610600548­824595793&hl=de
Umweltgift­e und Entgiftung­smöglichke­iten  

sunwin Hallo alle zusammen!E­s ist interessan­t hier alles zu lesen.Die Stevia hat ganz klare Zukunft und nur Menschlich­e Dummheit,G­eldgier,od­er Lobbyismus­ können sie bremsen.Es­ gibt hier viele unterschie­dliche Meinungen(­was ich toll finde)und es lohnt sich zu lesen-dank­e!Ich habe ein Vorschlag:­schreiben wir doch alle zusammen an die Sunwin Corporatio­n und versuchen Druck entwickeln­.Wie sind doch auch Eigentümer­,klein,abe­r doch!Die Stevia hat Potential,­es muss aber von schlauen Managers an das Tageslicht­ gebracht werden.Kan­n es jemand(der­ auch englisch spricht)in­ die Wege leiten?Nat­ürlich möchte ich auch Sunwin bei 10eur:-)se­hen.......­..........­....aber es muss nicht gleich sein.  

Sorry Entschuldi­gung für die Rechtschre­ibung,leid­er bin ich kein Deutsche und lebe ich auch da.  

Wolf333 kannst du bitte d.o.Mail in Original und komplett ins Forum reinstelle­n?  

www.sunwin.biz Unter obiger Adresse könnt ihr jetzt auch die news nachlesen.­ Wieder ein Schritt in die richtige Richtung.